Assessing Patient Engagement in Keratoconus Clinical Research
This study is looking into why people with keratoconus (a condition where the clear front part of your eye, the cornea, thins and bulges out like a cone) choose to join, leave, or rejoin clinical trials. There are no specific treatments being tested in this study. We want to understand what influences these decisions to make future research better and help find new treatments faster. You can join if you are 18 or older, have keratoconus, and haven't had treatment for it yet. The study will measure how many people decide to join a trial after 3 months and how many stay in a trial until it's finished after 12 months.
- Study design
- This is an observational study aiming to enroll 500 participants. It is not testing a specific treatment, but rather observing patient choices.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track patient participation for up to 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Assessing Patient Engagement in Keratoconus Clinical Research
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Rate of patients who decide to join in a keratoconus clinical trial3 months
- Number of keratoconus patients who remain in clinical trial until completion12 months